FDA drug class

Endothelin Receptor Antagonists list

Every FDA-approved prescription drug the FDA NDC directory tags with the Endothelin Receptor Antagonist [EPC] class, with brand names and DEA schedules.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

The FDA NDC directory lists 6 single-ingredient drugs in this class: ambrisentan, aprocitentan, atrasentan, bosentan, macitentan, sparsentan. Another 1 combination product include one of them.

Run it in Rivvi

Map Letairis and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Endothelin Receptor Antagonists (7)

Endothelin Receptor Antagonists: FDA Endothelin Receptor Antagonist class
DrugBrand namesTypeNDC listingsDEA schedule
AmbrisentanLetairisSingle ingredient26Not controlled
AprocitentanTryvioSingle ingredient1Not controlled
AtrasentanVanrafiaSingle ingredient1Not controlled
BosentanTracleerSingle ingredient14Not controlled
MacitentanOpsumitSingle ingredient15Not controlled
SparsentanFilspariSingle ingredient2Not controlled
Macitentan and tadalafilOpsynviCombination2Not controlled

FDA established pharmacologic class: Endothelin Receptor Antagonist [EPC].

Questions

What drugs are Endothelin Receptor Antagonists?

The FDA NDC directory lists 6 single-ingredient drugs in this class: ambrisentan, aprocitentan, atrasentan, bosentan, macitentan, sparsentan. Another 1 combination product include one of them.

Where does this list come from?

From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.

Related

Try it on your own data today.

Free to start. Most teams are using it the same day.